Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSTK1 | Q9Y2Q3 | 2/20 | 0.64 |
| ▸ | ENPEP | Q07075 | 5/20 | 0.59 |
| ▸ | LMNA | P02545 | 2/20 | 0.52 |
| ▸ | TSHR | P16473 | 1/20 | 0.52 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.52 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.52 |
| ▸ | FOLH1 | Q04609 | 2/20 | 0.50 |
| ▸ | FFAR4 | Q5NUL3 | 2/20 | 0.47 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.44 |
| ▸ | ANPEP | P15144 | 2/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3012513 | 1.00 | GSTK1 (0.64) | GSTK1ENPEPLMNATSHRNFKB1 | |
| SCHEMBL6361383 | 1.00 | GSTK1 (0.64) | GSTK1ENPEPLMNATSHRNFKB1 | |
| SCHEMBL9253547 | 1.00 | GSTK1 (0.64) | GSTK1ENPEPLMNATSHRNFKB1 | |
| SCHEMBL994189 | 0.98 | GSTK1 (0.63) | GSTK1ENPEPLMNATSHRNFKB1 | |
| SCHEMBL3018158 | 0.91 | ENPEP (0.59) | GSTK1ENPEPLMNATSHRNFKB1 | |
| SCHEMBL15956044 | 0.89 | TSHR (0.60) | GSTK1ENPEPLMNATSHRNFKB1 | |
| SCHEMBL21611884 | 0.85 | GSTK1 (0.57) | GSTK1ENPEPLMNATSHRNFKB1 | |
| SCHEMBL6809842 | 0.85 | GSTK1 (0.57) | GSTK1ENPEPLMNATSHRNFKB1 | |
| SCHEMBL18422675 | 0.85 | FOLH1 (0.60) | GSTK1ENPEPLMNATSHRNFKB1 | |
| SCHEMBL6805309 | 0.85 | GSTK1 (0.57) | GSTK1ENPEPLMNATSHRNFKB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1570835-B1 | Composition for the permanent deformation of the hair comprising at least one carboxydithiol | OREAL (FR) | 2010-10-20 | — | — | EP | claimed |
| US-20050208007-A1 | Composition to permanently reshape the hair containing at least one carboxydithiol | L'OREAL S.A. (FR) | 2005-09-22 | — | — | US | claimed |
| US-20050208007-A1 | Composition to permanently reshape the hair containing at least one carboxydithiol | L'OREAL S.A. (FR) | 2005-09-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050208007-A1 | Composition to permanently reshape the hair containing at least one carboxydithiol | CTH, BHMT2, CRAT | GSTK1 1598/4885ENPEP 564/4885LMNA 3481/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.